08/13/2025
6:01 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2025
6:00 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2025
3:17 PM | Galera Therapeutics (Issuer)
Sorensen Mel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:19 PM | Galera Therapeutics (Issuer)
Sussman Joel F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2025
4:05 PM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
5:13 AM | Galera Therapeutics (Filer)
| Form 8-K/A | |
02/26/2025
3:43 PM | Alleva Lawrence M (Reporting)
Galera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
12:22 PM | Galera Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
| Form SCHEDULE 13G | |
01/24/2025
8:04 AM | Galera Therapeutics (Filer)
| Form DEF 14A | |
01/13/2025
8:44 PM | Galera Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/13/2025
2:18 PM | Galera Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/02/2025
3:12 PM | CHANG NANCY T (Reporting)
Galera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:05 PM | FRIEDMAN MICHAEL R. (Reporting)
Galera Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2025
3:08 PM | FRIEDMAN MICHAEL R. (Reporting)
Galera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
6:11 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:42 PM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
6:17 AM | Galera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/15/2024
4:25 PM | Galera Therapeutics (Filer)
| Form NT 10-Q | |
10/18/2024
7:05 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
6:38 AM | Galera Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
09/04/2024
6:01 AM | Galera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
6:00 AM | Galera Therapeutics (Filer)
| Form DEF 14A | |
08/23/2024
6:00 AM | Galera Therapeutics (Filer)
| Form PRE 14A | |
08/20/2024
3:45 PM | Galera Therapeutics (Issuer)
Sorensen Mel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access